We are live on ! Find out more
CCXI icon

ChemoCentryx

Delisted

CCXI was delisted on the 19th of October, 2022.

70 hedge funds and large institutions have $216M invested in ChemoCentryx in 2015 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 27 increasing their positions, 22 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 22

6% more call options, than puts

Call options by funds: $721K | Put options by funds: $680K

0% more funds holding

Funds holding: 70 → 70 (0)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 7

1.33% less ownership

Funds ownership: 60.96% → 59.63% (-1.3%)

10% less capital inflows, than outflows

Capital inflows: $15.2M | Capital outflows: $17M

Holders
70
Holders Change
–
Holders Change %
0%
% of All Funds
1.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
7
Increased
27
Reduced
22
Closed
7
Calls
$721K
Puts
$680K
Net Calls
+$41K
Net Calls Change
+$9K

CCXI Hedge Fund Activity: Q2 2015 in Review

70 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx (CCXI) for Q2 2015, worth a combined $216M — up 7.9% from $200M a quarter earlier.

Fund positioning in CCXI was balanced in Q2 2015: 7 funds opened new positions, 7 closed out, 27 added to existing stakes and 22 trimmed.

The largest buyer was Redmile Group, adding an estimated $3.64M. The largest seller was BVF Inc, cutting an estimated $8.21M.

  • 70 institutional investors held ChemoCentryx (CCXI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $216M of ChemoCentryx stock for Q2 2015, up 7.9% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx positions in Q2 2015 and 7 closed out, a net change of 0 holders.
  • The largest ChemoCentryx buyer in Q2 2015 was Redmile Group, an estimated $3.64M added.
  • The largest ChemoCentryx seller in Q2 2015 was BVF Inc, an estimated $8.21M sold.

Based on aggregated 13F filings for Q2 2015.